ImmunityBio, Inc.

About

ImmunityBio is a vertically integrated, commercial-stage biotechnology company developing next-generation therapies designed to bolster the natural immune system to fight cancers and infectious diseases. The company’s portfolio includes immunotherapy and cell therapy platforms intended to drive and sustain an immune response for durable protection against disease. Notably, its product ANKTIVA has been designated an FDA Breakthrough Therapy and is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer CIS, activating NK cells and T cells. The company is currently hiring software engineers for UI/UX, AI, and full-stack roles, indicating a focus on building digital tools to support its biotech operations.